Ada Böhm

Ada Böhm

Auto-generated profile, based on publicly available information

Ada Böhm

IT4Innovations, VSB-TU Ostrava, Ostrava, Czech Republic

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in HETEROCYCLES
Verified
Journal Article
Open access
JIJán Imrich
Ján Imrich
ZFZdenka Fröhlichová
Zdenka Fröhlichová
JTJana Tomaščiková
Jana Tomaščiková
PKPavol Kristian
Pavol Kristian
IDIvan Danihel
Ivan Danihel
KKKarel D. Klika
Karel D. Klika

9 May 2023
Verified
Conference Paper
Open access
GPGianluca Palermo
Gianluca Palermo
GAG. Accordi
G. Accordi
DGDavide Gadioli
Davide Gadioli
EVE. Vitali
E. Vitali
CSC. Silvano
C. Silvano
PGP. Gschwandtner
P. Gschwandtner
Today digital revolution is having a dramatic impact on the pharmaceutical industry and the entire healthcare system. The implementation of machine learning, extreme-scale computer simulations, and big data analytics in the drug design and development process offers an excellent opportunity to lower the risk of investment and reduce the time to the patient. Within the LIGATE project 1, we aim to integrate, extend, and co-design best-in-class European components to design Computer-Aided Drug Design (CADD) solutions exploiting today's high-end supercomputers and tomorrow's Exascale resources, fostering European competitiveness in the field. The proposed LIGATE solution is a fully integrated workflow that enables to deliver the result of a virtual screening campaign for drug discovery with the highest speed along with the highest accuracy. The full automation of the solution and the possibility to run it on multiple supercomputing centers at once permit to run an extreme scale in silico drug discovery campaign in few days to respond promptly for example to a worldwide pandemic crisis.

28 May 2025
Verified
Conference Paper
Open access
LRLubomir Riha
Lubomir Riha
ABAda Böhm
Ada Böhm
OVOndřej Vysocký
Ondřej Vysocký
FVFilip Vaverka
Filip Vaverka
EBElisabetta Boella
Elisabetta Boella
EMElisa Molinari
Elisa Molinari

7 May 2024
Verified
Conference Paper
Open access
GPGianluca Palermo
Gianluca Palermo
GAG. Accordi
G. Accordi
DGDavide Gadioli
Davide Gadioli
YZY. Zhang
Y. Zhang
EVE. Vitali
E. Vitali
PGP. Gschwandtner
P. Gschwandtner
The COVID-19 pandemic demonstrates that a top priority for society, now and in the future, is to be able to respond quickly to diseases with effective treatments. Among the new tools that pharmaceutical industries and researchers have in their hands nowadays, there are the extensive computer simulations capable of evaluating in-silico the interaction between possible drugs and the target proteins. The central goal of the LIGATE project is to create and validate a leading application solution for drug discovery in High-Performance Computing (HPC) systems up to the exascale level. The overall project purpose is the automation of the drug design process, which is currently performed with substantial human effort throughout the different phases of the process: preparation of input parameters, management of data sets with billions of molecules, interaction with HPC queue management systems to handle jobs, and optimization of scoring function parameters and thresholds.

18 April 2018
Verified
Book Chapter
Closed access
PDF file
SBStanislav Böhm
Stanislav Böhm
JBJakub Beránek
Jakub Beránek
MŠMartin Šurkovský
Martin Šurkovský